ERG Awarded New Contract to Support FDA Center for Drug Evaluation and Research

The U.S. Food and Drug Administration's (FDA's) Center for Drug Evaluation and Research awarded ERG a new $20 million, 5-year contract to provide technical assistance to FDA in identifying, developing, enhancing, applying, and evaluating a wide range of quantitative and qualitative methods. ERG's work will draw upon decision science, risk analysis, social science, health outcomes research, health systems research, health economics, and other analytic disciplines. We will enable FDA to more comprehensively and rigorously analyze and measure effectiveness, quality, value, and other impacts on consumers, public health, healthcare, regulated industry, and other stakeholders.